Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Inventory (2020 - 2025)

PROCEPT BioRobotics has reported Inventory over the past 6 years, most recently at $70.7 million for Q4 2025.

  • Quarterly results put Inventory at $70.7 million for Q4 2025, up 25.86% from a year ago — trailing twelve months through Dec 2025 was $70.7 million (up 25.86% YoY), and the annual figure for FY2025 was $70.7 million, up 25.86%.
  • Inventory for Q4 2025 was $70.7 million at PROCEPT BioRobotics, up from $66.7 million in the prior quarter.
  • Over the last five years, Inventory for PRCT hit a ceiling of $70.7 million in Q4 2025 and a floor of $10.4 million in Q3 2021.
  • Median Inventory over the past 5 years was $41.9 million (2023), compared with a mean of $40.2 million.
  • Biggest five-year swings in Inventory: surged 209.47% in 2023 and later grew 2.88% in 2024.
  • PROCEPT BioRobotics' Inventory stood at $13.1 million in 2021, then soared by 117.11% to $28.5 million in 2022, then surged by 39.28% to $39.8 million in 2023, then surged by 41.28% to $56.2 million in 2024, then rose by 25.86% to $70.7 million in 2025.
  • The last three reported values for Inventory were $70.7 million (Q4 2025), $66.7 million (Q3 2025), and $67.0 million (Q2 2025) per Business Quant data.